Literature DB >> 19000923

Identification of tumor promotion marker genes for predicting tumor promoting potential of chemicals in BALB/c 3T3 cells.

Hideki Maeshima1, Katsutoshi Ohno, Yukimasa Tanaka-Azuma, Shigeru Nakano, Toshihiro Yamada.   

Abstract

Tumor promoters can cause development of tumors in initiated cells and the majority of them are non-genotoxic carcinogens. The detection of tumor promoters is important for the prevention of cancer. The in vitro two-stage transformation assay, using BALB/c 3T3 cells, is a useful system, and benefits from a convenient protocol and high predictability of mammalian carcinogenicity. But these assays are time-consuming and often require expertise for microscopic observation. To construct an in vitro tumor promoting activity test system, we performed large-scale gene expression analyses, using DNA microarrays, of BALB/c 3T3 cells following treatment with nine chemicals that are known to induce tumor promotion: TPA, zinc chloride, sodium orthovanadate, okadaic acid, insulin, lithocolic acid, phenobarbital sodium, sodium saccharide, sodium arsenite. As a result of DNA microarray and real time PCR analyses, 22 marker genes were identified. These consisted of genes related to cell cycle, regulation of transcription, anti-apoptosis, and positive regulation of cell proliferation. There was a correlation between these 22 marker genes and the cell transformation assay results in BALB/c 3T3 cells. These results suggest that this tumor promoting activity test system, based on 22 marker genes, can become a valuable tool for screening potential tumor promoters.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19000923     DOI: 10.1016/j.tiv.2008.10.005

Source DB:  PubMed          Journal:  Toxicol In Vitro        ISSN: 0887-2333            Impact factor:   3.500


  5 in total

1.  TNFAIP8: a new effector for Galpha(i) coupling to reduce cell death and induce cell transformation.

Authors:  Benoit Laliberté; Ariel M Wilson; Houman Nafisi; Helen Mao; Yi Yuen Zhou; Mireille Daigle; Paul R Albert
Journal:  J Cell Physiol       Date:  2010-11       Impact factor: 6.384

2.  Insulin-IGF signaling affects cell transformation in the BALB/c 3T3 cell model.

Authors:  Doerte Poburski; Christiane Leovsky; Josefine Barbara Boerner; Luisa Szimmtenings; Michael Ristow; Michael Glei; René Thierbach
Journal:  Sci Rep       Date:  2016-11-16       Impact factor: 4.379

3.  Carcinogenicity risk assessment supports the chronic safety of dapagliflozin, an inhibitor of sodium-glucose co-transporter 2, in the treatment of type 2 diabetes mellitus.

Authors:  Timothy P Reilly; Michael J Graziano; Evan B Janovitz; Thomas E Dorr; Craig Fairchild; Francis Lee; Jian Chen; Tai Wong; Jean M Whaley; Mark Tirmenstein
Journal:  Diabetes Ther       Date:  2014-01-29       Impact factor: 2.945

4.  Global analysis of posttranscriptional gene expression in response to sodium arsenite.

Authors:  Lian-Qun Qiu; Sarah Abey; Shawn Harris; Ruchir Shah; Kevin E Gerrish; Perry J Blackshear
Journal:  Environ Health Perspect       Date:  2014-11-21       Impact factor: 9.031

5.  Improvement of the BALB/c-3T3 cell transformation assay: a tool for investigating cancer mechanisms and therapies.

Authors:  Doerte Poburski; René Thierbach
Journal:  Sci Rep       Date:  2016-09-09       Impact factor: 4.379

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.